About Blackfynn

Blackfynn was formed to change the way neurological diseases are treated. Our multidisciplinary team of deep domain experts is as diverse as the problems we solve.

Why we’re here.

New tools and technologies are generating vast quantities of highly complex and diverse data. Electrical recordings, radiology imaging, genomics, pathology, neurochemistry, device and patient clinical data — together — could hold the keys to understanding the basis of human disease. Breakthrough discoveries that could lead to novel therapeutics have been hindered by an inability to see, use, collaborate around, analyze and interrogate all data types in combination to find new data patterns.

We built our platform to solve this problem. We came together to improve the lives of the more than one billion people worldwide who are living with Epilepsy, Alzheimer’s disease, Parkinson’s disease, ALS and other neurological diseases.

Who we are.

Misty Ahmed

Misty Ahmed

Full Stack Engineer

Chris Baglieri

Chris Baglieri

SVP, Engineering

Cameron Baney

Cameron Baney

Software Engineer

Jonathon Brouse

Jonathon Brouse

Site Reliability Engineer

Amanda Christini, M.D.

Amanda Christini, M.D.

Co-Founder • President

Stephen Cirner

Stephen Cirner

Full Stack Engineer

Jillian Cunningham

Jillian Cunningham

Grants and Operations Coordinator

Erin Griffault

Erin Griffault

Head of Operations & Talent

Mark Hollenbeck

Mark Hollenbeck

Scientific Software Engineer

Kevin Jackson

Kevin Jackson

Head of Design

Christian Lohr

Christian Lohr

Front End Engineer

Silvia Lopez de Diego

Silvia Lopez de Diego

Scientific Software Engineer

Rohan Shah

Rohan Shah

Software Engineer

Jim Snavely

Jim Snavely

Lead Software Engineer

Nate Vecchiarelli

Nate Vecchiarelli

Software Engineer

Joost Wagenaar, PhD

Joost Wagenaar, PhD

Co-Founder • VP, Scientific Applications

Our board of directors.

Simba Gill, PhD

Chairman

Michael Rabson, PhD, JD

Director

Our scientific advisors.

Brian Litt, M.D.

Blackfynn co-founder and Professor of Neurology and Biomedical Engineering, University of Pennsylvania

Zack Ives, PhD

Blackfynn co-founder and Professor of Computer Science, University of Pennsylvania

John Detre, M.D.

Director, Center for Functional Imaging, Professor of Neurology, Professor of Radiology, University of Pennsylvania

Ray Dorsey, M.D.

Professor of Neurology and Director, Center for Human Experimental Therapeutics, University of Rochester

Jacqueline French, M.D.

Professor of Neurology, NYU Comprehensive Epilepsy Center, New York University, Director Epilepsy Study Consortium

Sean Grady, M.D.

Professor and Chair, Department of Neurosurgery, University of Pennsylvania

Tim Harris, PhD

Venture Partner SV Life Sciences; Formerly SVP Precision Medicine, Biogen

Annamaria Vezzani, PhD

Head, Department of Neuroscience and Laboratory of Experimental Neurology, Mario Negri Institute for Pharmacological Research, Milano, Italy

Karen Wilcox, PhD

Professor and Chair, Director: Anticonvulsant Drug Development (ADD) Program, Department of Pharmacology & Toxicology, University of Utah

Greg Worrell, M.D., PhD

Chair, Division of Clinical Neurophysiology, Department of Neurology, Mayo Clinic

icon-medicine Menu blackfynn_logo_mark_RGB_FULL Close menu Dribbble GitHub icon-clinical-services Twitter Google icon-devices LinkedIn icon Monogram